|
⚲
|
| Keyboard |
| Brady James Aloysius
✚
|
|
|---|---|
| CIK # | 0001916987 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001916987] | |
| 4 | [0001916987] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Xeris Biopharma Holdings Inc | |
| Brady James Aloysius | |
| Verona Pharma PLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Verona Pharma PLC VRNA
Share Options (Right to Buy) · derivative
|
2025-10-07 | Disposed to issuer | 240,000 | ||
|
Verona Pharma PLC VRNA
Share Options (Right to Buy) · derivative
|
2025-10-07 | Disposed to issuer | 288,000 | ||
|
Verona Pharma PLC VRNA
Share Options (Right to Buy) · derivative
|
2025-10-07 | Disposed to issuer | 96,000 | ||
|
Verona Pharma PLC VRNA
Ordinary Shares
|
2025-10-07 | Disposed to issuer | 23,176 | ||
|
Verona Pharma PLC VRNA
Ordinary Shares
|
2025-10-07 | Disposed to issuer | 72,000 | ||
|
Verona Pharma PLC VRNA
Ordinary Shares
|
2025-10-07 | Option exercise | 72,000 | ||
|
Verona Pharma PLC VRNA
Restricted Share Unit · derivative
|
2025-10-07 | Option exercise | 72,000 | ||
|
Verona Pharma PLC VRNA
Ordinary Shares
|
2025-08-01 | Option exercise | 24,000 | $0.00 | |
|
Verona Pharma PLC VRNA
Ordinary Shares
|
2025-08-01 | Sell | 824 | $13.14 | 10,827 |
|
Verona Pharma PLC VRNA
Restricted Stock Units · derivative
|
2025-08-01 | Option exercise | 24,000 | $0.00 | |
|
Verona Pharma PLC VRNA
Restricted Share Units · derivative
|
2025-04-25 | Grant | 96,000 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-03-28 | Grant | 100,000 | $0.00 | |
|
Verona Pharma PLC VRNA
Share Options (Right to Buy) · derivative
|
2024-04-29 | Grant | 240,000 | $0.00 | |
|
Verona Pharma PLC VRNA
Share Options (Right to Buy) · derivative
|
2023-04-28 | Grant | 96,000 | $0.00 | |
|
Verona Pharma PLC VRNA
Share Options (Right to Buy) · derivative
|
2022-03-14 | Grant | 288,000 | $0.00 |